Brief: Cardiol Therapeutics Inc Receives Health Canada Approval For Phase II Clinical Trial Of Cardiolrx For Acute Myocarditis
25/10/2021 12:47
Oct 25 (Reuters) - Cardiol Therapeutics Inc CRDL.TO :
* CARDIOL THERAPEUTICS RECEIVES HEALTH CANADA APPROVAL FOR
PHASE
II CLINICAL TRIAL OF CARDIOLRX FOR ACUTE MYOCARDITIS
Further company coverage: CRDL.TO
Recent news on Cardiol Therapeutics
See all newsBrief: Cardiol Therapeutics Initiated Pivotal Phase Iii Maveric Trial Of Cardiolrx In Recurrent Pericarditis
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:11 AM
Brief: Cardiol Therapeutics Files For Mixed Shelf Of Up To $150 Million
Brief: Cardiol Therapeutics Enrolls First Patient In Pivotal Phase III Maveric Trial In Recurrent Pericarditis